ARKG vs SCHD
ARK Genomic Revolution ETF vs Schwab US Dividend Equity ETF
ARKG—
ARK Genomic Revolution ETF
Companies advancing genomics and molecular biology.
Expense: —Yield: —
SCHD—
Schwab US Dividend Equity ETF
High-quality US dividend-paying stocks.
Expense: —Yield: —
Side-by-side metrics
| Metric | ARKG | SCHD |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | ARK | Schwab |
ARKG top holdings
Holdings data unavailable for ARKG.
SCHD top holdings
Holdings data unavailable for SCHD.
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology.
About SCHD
SCHD (Schwab US Dividend Equity ETF) is High-quality US dividend-paying stocks.